From: Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
Intention to Treat
Per Protocol
UBT
QT
OAR
CI 95%
Negative
38 (70.4%)
20 (40.4%)
p = 0.009
37 (77.1%)
20 (46.5%)
p = 0.003
Positive
16 (29.6%)
25 (55.6%)
11 (22.9%)
23 (53.5%)
N
54
45
OR 1.58 (1.1–2.29)
48*
43
OR 1.65 (1.1–2.36)